Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 346โ€“360 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4353
EMD Gene (Emery-Dreifuss Muscular Dystrophy Type 1) NGS Test

This test analyzes the entire EMD gene for mutations associated with Emery-Dreifuss muscular dystrophy type 1.

Peripheral whole blood (EDTA) or FTA card 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EMD gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (Indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No special preparation is required."]
Indications
["Diagnosis of Emery-Dreifuss muscular dystrophy type 1", "Carrier status testing in at-risk family members", "Genetic counseling for families with EDMD1"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G71.0
Clinical summary
This test analyzes the entire EMD gene for mutations associated with Emery-Dreifuss muscular dystrophy type 1.
TEST-1032
Enhanced Liver Fibrosis (ELF) Panel Test

This diagnostic test evaluates liver fibrosis severity using serum biomarkers.

Serum Next day (if collected Mon/Thu by 4pm) 900.00 AED
View
View test specifications and preparation
What it measures
["Hyaluronic acid", "Procollagen III amino-terminal peptide (PIIINP)", "Tissue inhibitor of metalloproteinase 1 (TIMP-1)"]
Parameters
[{"name": "Hyaluronic acid", "reference_range": null}, {"name": "PIIINP", "reference_range": null}, {"name": "TIMP-1", "reference_range": null}, {"name": "ELF Score", "reference_range": "=9.8 (Advanced/Cirrhosis)"}]
Preparation
["Overnight fasting (10-12 hours) mandatory", "Water is permitted during fasting", "Inform phlebotomist of all current medications and supplements", "Do not discontinue prescribed medications without physician consultation"]
Indications
["Monitoring chronic liver disorders", "Assessing fibrosis progression", "Guiding treatment decisions in fatty liver disease", "Guiding treatment decisions in viral hepatitis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94862-9 ICD-10: K74.0, Z13.89, K74.69
Clinical summary
This diagnostic test evaluates liver fibrosis severity using serum biomarkers.
TEST-6349
ENO3 Gene Glycogen Storage Disease Type 13 (GSD XIII) Genetic Test

This test evaluates the entire ENO3 gene for mutations associated with Glycogen Storage Disease Type 13 (GSD XIII). It identifies pathogenic variants, including single nucleotide v...

Peripheral Whole Blood (EDTA) or FTA Dried Blood Spot 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ENO3 gene sequence", "Copy Number Variants (CNVs) in ENO3 gene"]
Parameters
[]
Preparation
["No special preparation such as fasting is required."]
Indications
["Suspected Glycogen Storage Disease Type 13", "Unexplained exercise intolerance", "Recurrent muscle cramps"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77784-8 ICD-10: E74.09
Clinical summary
This test evaluates the entire ENO3 gene for mutations associated with Glycogen Storage Disease Type 13 (GSD XIII). It identifies pathogenic variants, including single nucleotide variants, insertions/deletions, and copy number variations.
TEST-4081
ENPP1 Gene Arterial Calcification Type 1 (GACI) Genetic Test

This genetic test identifies pathogenic variants in the ENPP1 gene, confirming a diagnosis of Generalized Arterial Calcification of Infancy (GACI) type 1.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ENPP1 gene"]
Parameters
[]
Preparation
["No fasting required.", "Pediatric phlebotomist will collect a small blood sample."]
Indications
["Infants with suspected GACI type 1", "Family history of GACI type 1", "Genetic counseling for at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88518-0 ICD-10: Q28.2
Clinical summary
This genetic test identifies pathogenic variants in the ENPP1 gene, confirming a diagnosis of Generalized Arterial Calcification of Infancy (GACI) type 1.
TEST-5314
ENPP1 Gene Cole Disease Genetic Test

This genetic test analyzes the ENPP1 gene for mutations associated with Cole disease.

Whole blood (EDTA), extracted DNA, or FTA card 21โ€“28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ENPP1 gene", "Coding regions and splice sites of the ENPP1 gene"]
Parameters
[]
Preparation
["No fasting required", "Complete a pre-test genetic counseling session", "Provide a detailed three-generation family pedigree"]
Indications
["Suspected Cole disease based on clinical presentation", "Family history suggestive of Cole disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98349-2 ICD-10: Q82.8, Z15.89, Z13.79
Clinical summary
This genetic test analyzes the ENPP1 gene for mutations associated with Cole disease.
TEST-6254
Enterokinase Deficiency (TMPRSS15 Gene) Genetic Test

This genetic test analyzes the entire coding sequence and CNVs of the TMPRSS15 gene to detect pathogenic variants causing congenital enterokinase deficiency.

Peripheral whole blood (2โ€“5 mL in EDTA) or buccal swab (infants) 3โ€“4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TMPRSS15 gene", "Single nucleotide variants (SNV)", "Small insertions/deletions (indel)", "Copy number variants (CNV)"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the lab of any relevant family history."]
Indications
["Infants or children presenting with unexplained hypoproteinaemia, oedema, and growth faltering.", "Confirmation of suspected congenital enterokinase deficiency.", "Identification of pathogenic variants in the TMPRSS15 gene.", "Family planning for families with an affected child."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E88.89
Clinical summary
This genetic test analyzes the entire coding sequence and CNVs of the TMPRSS15 gene to detect pathogenic variants causing congenital enterokinase deficiency.
TEST-5432
EOGT Gene Adams-Oliver Syndrome Type 4 Genetic Test

This test identifies pathogenic variants in the EOGT gene associated with Adams-Oliver syndrome type 4.

Peripheral whole blood (or pre-extracted DNA) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EOGT gene", "Copy Number Variations (CNV) in the EOGT gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Clinical features suggestive of Adams-Oliver syndrome type 4", "Family history of Adams-Oliver syndrome type 4", "Genetic counselling recommendation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95887-3 ICD-10: Q87.2, Q84.8, Z13.79
Clinical summary
This test identifies pathogenic variants in the EOGT gene associated with Adams-Oliver syndrome type 4.
TEST-3287
EPAS1 Gene Erythrocytosis (Familial Type 4) Genetic Test

This test evaluates the EPAS1 gene for mutations associated with familial erythrocytosis type 4.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["EPAS1 gene sequence", "Copy Number Variations (CNV) in EPAS1"]
Parameters
[]
Preparation
["Detailed clinical history including prior hematological events and family history of erythrocytosis.", "Mandatory genetic counselling session to construct a pedigree chart."]
Indications
["Suspected familial erythrocytosis type 4", "Family screening for EPAS1 mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: D75.0, D75.1, Z15.89
Clinical summary
This test evaluates the EPAS1 gene for mutations associated with familial erythrocytosis type 4.
TEST-6255
EPHX2 Gene Modifier Analysis for Familial Hypercholesterolemia (LDLR Defect) via NGS Test

This test analyzes the EPHX2 gene to identify variants that modify the severity and drug response associated with LDLR-related familial hypercholesterolemia.

Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["EPHX2 gene variants", "Modifier effect on LDL receptor activity", "Cardiovascular risk prediction"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed lipid-lowering medication"]
Indications
["In-depth lipid disorder phenotyping", "Tailored statin or intensive therapy decisions", "Screening suspected familial hypercholesterolemia cases", "Risk prediction studies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88214-3 ICD-10: E78.01
Clinical summary
This test analyzes the EPHX2 gene to identify variants that modify the severity and drug response associated with LDLR-related familial hypercholesterolemia.
TEST-1055
Episodic Ataxia Type 2 Hotspot Test

This test identifies specific pathogenic mutations in the CACNA1A gene associated with Episodic Ataxia Type 2 (EA2). It is used for definitive diagnosis in patients presenting with...

Whole Blood (Lavender Top EDTA Tube, 2 mL min) 5 Business Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the CACNA1A gene", "Presence of known EA2 hotspot variants"]
Parameters
[]
Preparation
["No fasting required", "Collect 2 mL whole blood in a Lavender Top (EDTA) tube", "Refrigerate sample immediately", "Ship via temperature-controlled cold-chain logistics"]
Indications
["Clinical suspicion of Episodic Ataxia Type 2", "Documented family history of EA2", "Differential diagnosis of ataxia, vertigo, or migraine"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21631-6 ICD-10: G11.8
Clinical summary
This test identifies specific pathogenic mutations in the CACNA1A gene associated with Episodic Ataxia Type 2 (EA2). It is used for definitive diagnosis in patients presenting with characteristic symptoms.
TEST-3839
ESR1 Gene Estrogen Resistance Genetic Test

This genetic test identifies pathogenic variants in the ESR1 gene associated with estrogen resistance.

Peripheral Whole Blood 21โ€“28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ESR1 gene", "Estrogen receptor alpha gene mutations"]
Parameters
[]
Preparation
[]
Indications
["Family history of estrogen resistance", "Endocrinologists seeking personalised hormone therapy guidance", "Fertility specialists investigating unexplained infertility", "Anti-aging physicians exploring hormone optimisation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93026-2 ICD-10: Z15.89
Clinical summary
This genetic test identifies pathogenic variants in the ESR1 gene associated with estrogen resistance.
TEST-4399
ETHE1 Gene Ethylmalonic Encephalopathy Genetic Test

This test identifies pathogenic variants in the ETHE1 gene associated with ethylmalonic encephalopathy.

Whole Blood, Extracted DNA, Dried Blood Spot 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ETHE1 gene coding exons", "ETHE1 gene conserved splice sites"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid blood collection during acute illness"]
Indications
["Suspected ethylmalonic encephalopathy", "Family history of ethylmalonic encephalopathy", "Unexplained neurological symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95207-8 ICD-10: E72.51
Clinical summary
This test identifies pathogenic variants in the ETHE1 gene associated with ethylmalonic encephalopathy.
TEST-1078
Ethosuximide Test

This test measures the concentration of ethosuximide in the serum to ensure therapeutic levels for seizure control while minimizing toxicity.

Serum 2โ€“3 weeks (sample must be received by the 7th of the month) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum trough concentration of ethosuximide"]
Parameters
[{"name": "Ethosuximide", "reference_range": "40โ€“100 ยตg/mL"}]
Preparation
["Collect sample immediately before the next oral dose", "Ensure patient has not missed a dose unless instructed by physician"]
Indications
["Monitoring ethosuximide therapy", "Assessing adherence", "Investigating potential toxicity", "Adjusting dosage"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3474-6 ICD-10: Z51.81, G40.909
Clinical summary
This test measures the concentration of ethosuximide in the serum to ensure therapeutic levels for seizure control while minimizing toxicity.
TEST-3142
ETV6 Gene Thrombocytopenia Type 5 Genetic Test

This test evaluates the ETV6 gene for variants associated with hereditary thrombocytopenia type 5.

Peripheral whole blood (EDTA) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)", "Full ETV6 gene sequence"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required", "Genetic counseling session recommended"]
Indications
["Suspected hereditary thrombocytopenia type 5", "Evaluation of bleeding risk", "Family history of ETV6-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76905-3 ICD-10: D69.41
Clinical summary
This test evaluates the ETV6 gene for variants associated with hereditary thrombocytopenia type 5.
TEST-1079
Everolimus Blood Test (Therapeutic Drug Monitoring)

This diagnostic test evaluates the concentration of everolimus in whole blood to optimize therapeutic dosing.

Whole Blood (EDTA) 24 to 48 hours 800.00 AED
View
View test specifications and preparation
What it measures
["Everolimus concentration"]
Parameters
[{"name": "Everolimus", "reference_range": null}]
Preparation
["Schedule blood draw exactly 12 hours after last dose", "Provide exact time and amount of last dose"]
Indications
["Post-transplant monitoring", "Dose adjustment guidance", "Monitoring for toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 41690-2 ICD-10: Z94.0, T86.1, Z79.899
Clinical summary
This diagnostic test evaluates the concentration of everolimus in whole blood to optimize therapeutic dosing.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area